Gastroenterologia

Revisão | Tratamento da insuficiência hepática aguda e transplante hepático.

16 Ago, 2022 | 12:32h

CAQ Corner: Acute liver failure management and liver transplantation – Liver Transplantation

 

---

Diretriz de consenso | Tromboprofilaxia para prevenção de tromboembolismo venoso em pacientes internados com cirrose.

15 Ago, 2022 | 13:34h

Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH – Journal of Thrombosis and Haemostasis

 

---

Insuficiência hepática aguda pediátrica: reexaminando características clínicas principais, tratamento atual e prospectos de pesquisa.

15 Ago, 2022 | 13:19h

Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects – Liver Transplantation

 

---

Diretriz clínica ACG | Gastroparesia.

9 Ago, 2022 | 17:38h

ACG Clinical Guideline: Gastroparesis – The American Journal of Gastroenterology

Conteúdos relacionados: United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis – UEG Journal

 

---

Diretriz de posicionamento | Uso de albumina na cirrose hepática.

9 Ago, 2022 | 17:36h

Position statement on the use of albumin in liver cirrhosis – Annals of Hepatology

 

---

Estudo de coorte | Adultos com diabetes tipo 2 e doença hepática gordurosa não alcoólica têm risco aumentado para hipoglicemia grave.

9 Ago, 2022 | 16:48h

Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease – JAMA Network Open

Comentário: Consider Fatty Liver Disease for Hypoglycemia Risk in Diabetes – JAMA Network Open (necessário cadastro gratuito)

 

Comentário no Twitter

In this cohort study, participants with type 2 diabetes and nonalcoholic fatty liver disease without cirrhosis had a 26% increased risk of severe hypoglycemia diabetes independent of obesity status. https://t.co/Zh9tHkOmOa

— JAMA Network Open (@JAMANetworkOpen) February 23, 2022

 

---

Câncer gástrico | Diretriz de prática clínica ESMO para diagnóstico, tratamento e seguimento.

5 Ago, 2022 | 17:26h

Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up – Annals of Oncology

 

---

Câncer esofágico | Diretriz de prática clínica ESMO para diagnóstico, tratamento e seguimento.

5 Ago, 2022 | 17:24h

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up – Annals of Oncology

 

---

Estudo de caso controle | Benefícios da sobrevida do transplante hepático com doador vivo.

5 Ago, 2022 | 17:18h

Survival Benefit of Living-Donor Liver Transplant – JAMA Surgery

Comentários:

Just How Low a Model for End-stage Liver Disease Score Benefits From Living-Donor Liver Transplant? – JAMA Surgery (gratuito por tempo limitado)

Low MELD Score No Barrier to Long Survival After Living-Donor Transplant — End-stage liver disease patients with scores as low as 11 achieved survival of 13 years or beyond – MedPage Today (necessário cadastro gratuito)

 

---

Revisão | Tratamento da descompensação hepática na doença hepática crônica avançada: ascite, hiponatremia e sangramento de varizes gastroesofágicas.

5 Ago, 2022 | 17:10h

Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding – Clinical Drug Investigation

Conteúdos relacionados: Overview of Complications in Cirrhosis – Journal of Clinical and Experimental Hepatology

 

---